Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Sanofi pays SK $52M as children's pneumococcal shot enters ph. 3
Sanofi is handing SK bioscience 50 million euros ($52 million) to take their next-gen pneumococcal conjugate vaccine program into phase 3.
James Waldron
Dec 23, 2024 8:05am
Sanofi scoops up China rights to Cytokinetics' heart disease med
Dec 20, 2024 11:07am
Sanofi, Teva tout midstage win for TL1A antibody in Crohn’s, UC
Dec 17, 2024 10:30am
Gilead's O'Day relishes reunion as Berger agrees to leave Sanofi
Dec 13, 2024 5:20am
40% layoffs break Belharra's tidal wave
Dec 9, 2024 4:52pm
Nuvig raises $161M with 4 Big Pharmas in tow
Dec 5, 2024 7:00am
